Rocket Lab (NASDAQ:RKLB) Stock Price Down 4.6% – Here’s Why

Shares of Rocket Lab Corporation (NASDAQ:RKLB) fell 4.6% during mid-day trading on Friday . The company traded as low as $63.50 and last traded at $64.39. Approximately 18,410,396 shares were traded during trading, a decline of 22% from the average session volume of 23,475,879 shares. The stock had previously closed at $67.53.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Launch and defense businesses continue to build momentum. Rocket Lab has reached 93 Electron launches, while its HASTE hypersonic test vehicle is supporting Pentagon missions. The company’s expanding defense portfolio could provide recurring revenue and diversify it beyond commercial launch services. Rocket Lab’s HASTE Is Flying Hypersonic Missions for the Pentagon
• Positive Sentiment: Analysts see potential for a rebound. A hammer chart pattern has suggested possible technical support, while analysts have revised earnings expectations higher. Rocket Lab’s reported consensus rating remains “Moderate Buy,” with an average price target of $110.65, although that view depends on substantial future execution. Why Rocket Lab Could Be a Bottom-Fishing Opportunity
• Neutral Sentiment: Iridium shareholders are preparing to vote on the proposed transaction. The vote represents a key milestone for Rocket Lab’s pending approximately $8 billion acquisition, but final approval and closing remain subject to shareholder and regulatory processes. Iridium Sets Shareholder Vote on Rocket Lab Acquisition
• Negative Sentiment: SpaceX has raised a regulatory risk around the Iridium deal. In comments to the Federal Communications Commission, SpaceX said alleged anticompetitive conduct by Iridium “hangs as a cloud” over the transaction. SpaceX does not formally oppose the deal, but the filing could lead to additional scrutiny, delays or conditions—making the acquisition harder to value. SpaceX Flags Iridium Deal to the FCC
• Negative Sentiment: Neutron remains the largest execution risk. Investors are increasingly focused on reports that the medium-lift rocket’s debut could slip into 2027. A delay would postpone a major growth catalyst and extend development spending, while much of Rocket Lab’s current revenue still comes from satellites and space systems. Rocket Lab’s Neutron Timeline Remains a Key Risk
• Negative Sentiment: Profitability and valuation concerns remain. Rocket Lab’s latest quarterly revenue exceeded estimates, but its loss per share was wider than expected, and analysts still expect a full-year loss. With a roughly $38 billion market value and a high-beta stock profile, investors have little tolerance for delays or weaker growth.
• Negative Sentiment: Multiple insider sales have added pressure. Executives sold approximately $5.5 million of shares, including transactions by the CFO and COO. The sales were made under pre-arranged Rule 10b5-1 plans to cover tax withholding, reducing their significance, but the lack of insider buying may still weigh on sentiment.

Analysts Set New Price Targets

A number of brokerages recently commented on RKLB. BTIG Research reaffirmed a “hold” rating on shares of Rocket Lab in a research report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft increased their price target on Rocket Lab from $73.00 to $120.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Needham & Company LLC restated a “buy” rating on shares of Rocket Lab in a report on Tuesday, August 11th. Morgan Stanley reaffirmed an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Finally, Craig Hallum increased their target price on Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, June 29th. Three equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $110.65.

Rocket Lab Price Performance

The firm has a market cap of $38.53 billion, a P/E ratio of -238.47 and a beta of 2.60. The company has a fifty day moving average of $78.66 and a 200-day moving average of $85.12. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The firm had revenue of $234.07 million for the quarter, compared to analysts’ expectations of $231.62 million. On average, sell-side analysts anticipate that Rocket Lab Corporation will post -0.2 EPS for the current fiscal year.

Insider Buying and Selling at Rocket Lab

In other Rocket Lab news, CEO Peter Beck sold 1,298,622 shares of the stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $84.92, for a total value of $110,278,980.24. Following the completion of the sale, the chief executive officer owned 2,715,181 shares in the company, valued at approximately $230,573,170.52. This trade represents a 32.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Bradford Clevenger sold 15,051 shares of Rocket Lab stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the transaction, the insider directly owned 458,924 shares in the company, valued at approximately $31,954,878.12. This represents a 3.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,482,622 shares of company stock valued at $306,340,164 in the last quarter. 8.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Rocket Lab

Several institutional investors have recently added to or reduced their stakes in RKLB. Corient Private Wealth LP increased its stake in shares of Rocket Lab by 795.2% during the 2nd quarter. Corient Private Wealth LP now owns 476,241 shares of the rocket manufacturer’s stock worth $48,410,000 after purchasing an additional 423,039 shares during the last quarter. Amundi increased its position in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after buying an additional 396,639 shares during the period. HighTower Advisors LLC lifted its stake in Rocket Lab by 4.2% in the 2nd quarter. HighTower Advisors LLC now owns 109,226 shares of the rocket manufacturer’s stock worth $11,103,000 after purchasing an additional 4,407 shares in the last quarter. Groupe la Francaise purchased a new stake in shares of Rocket Lab in the second quarter worth $725,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Rocket Lab in the second quarter worth approximately $1,071,000. Institutional investors own 71.78% of the company’s stock.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.